Fmr LLC Celldex Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 5,439,118 shares of CLDX stock, worth $148 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,439,118

Previous 5,380,091 1.1%

Holding current value

$148 Million

Previous $97.6 Million 13.35%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$15.13 - $21.65 $893,078 - $1.28 Million	59,027 Added 1.1%	5,439,118 $111 Million
Q1 2025 May 12, 2025	BUY	$18.15 - $27.6 $9.48 Million - $14.4 Million	522,423 Added 10.75%	5,380,091 $97.6 Million
Q4 2024 Feb 13, 2025	SELL	$23.31 - $32.4 $27.2 Million - $37.8 Million	-1,166,748 Reduced 19.37%	4,857,668 $123 Million
Q3 2024 Nov 13, 2024	SELL	$32.06 - $44.56 $57.9 Million - $80.4 Million	-1,804,748 Reduced 23.05%	6,024,416 $205 Million
Q2 2024 Aug 13, 2024	SELL	$32.76 - $42.56 $62.1 Million - $80.7 Million	-1,896,877 Reduced 19.5%	7,829,164 $290 Million
Q1 2024 May 13, 2024	BUY	$35.22 - $51.88 $94.2 Million - $139 Million	2,675,632 Added 37.95%	9,726,041 $408 Million
Q4 2023 Feb 13, 2024	SELL	$22.61 - $40.65 $875,255 - $1.57 Million	-38,711 Reduced 0.55%	7,050,409 $280 Million
Q3 2023 Nov 13, 2023	BUY	$25.45 - $37.46 $31,812 - $46,825	1,250 Added 0.02%	7,089,120 $195 Million
Q2 2023 Aug 11, 2023	BUY	$30.29 - $38.28 $205,729 - $259,997	6,792 Added 0.1%	7,087,870 $240 Million
Q1 2023 May 11, 2023	BUY	$34.78 - $47.43 $560,097 - $763,812	16,104 Added 0.23%	7,081,078 $255 Million
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $1.36 Million - $2.23 Million	49,131 Added 0.7%	7,064,974 $315 Million
Q3 2022 Nov 10, 2022	BUY	$22.7 - $37.57 $61,267 - $101,401	2,699 Added 0.04%	7,015,843 $197 Million
Q2 2022 Aug 12, 2022	BUY	$20.5 - $37.33 $59,265 - $107,921	2,891 Added 0.04%	7,013,144 $189 Million
Q1 2022 May 13, 2022	BUY	$27.64 - $39.32 $295,001 - $419,662	10,673 Added 0.15%	7,010,253 $239 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $49.4 Million - $77.9 Million	1,384,247 Added 24.65%	6,999,580 $270 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $152 Million - $294 Million	5,249,038 Added 1433.01%	5,615,333 $303 Million
Q2 2021 Aug 13, 2021	BUY	$20.71 - $35.37 $7.59 Million - $13 Million	366,295 New	366,295 $12.2 Million

Others Institutions Holding CLDX

# of Institutions

199

Shares Held

68.2M

Call Options Held

219K

Put Options Held

238K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.27B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account